Evidence-Based Reviews

Cats, toxoplasmosis, and psychosis: Understanding the risks

Author and Disclosure Information

 

References

Family outbreaks have also been described that involve multiple children who played in an infected sandbox or dirt pile.5 Similarly, an outbreak has been reported in a riding stable that was home to infected cats. Infective oocysts were thought to have become aerosolized and breathed in by the patrons.6 Multiple other possible modes of transmission are being investigated, including sexual transmission among humans.7

Human infections are not always benign

In most human T. gondii cases, the infected individual experiences mild, flu-like symptoms, often with enlarged lymph nodes, or has no symptoms.1 Thus, most people who have been infected with T. gondii are unaware because clinicians do not routinely test for it.

There are 3 exceptions to this otherwise benign clinical picture. The first is cerebral toxoplasmosis, which occurs in individuals who are immunosuppressed because they have AIDS or are receiving treatment for cancer or organ transplantation. Cerebral toxoplasmosis can be severe and was a common cause of death in patients with AIDS before the development of effective AIDS treatments.

The second exception is congenital toxoplasmosis, when an infection occurs in a pregnant woman. Such infections can cause severe damage to the developing fetus, including abortion, stillbirth, and brain damage. Congenital toxoplasmosis infections occur in approximately 1 of every 10,000 births in the United States, or approximately 3,800 each year.8 As a result, pregnant women are advised not to change their cat’s litter and to be tested for evidence of T. gondii infection.

The third exception is eye disease. Toxoplasmosis is one of the most common causes of eye disease, especially of the retina. Each year in the United States, approximately 4,800 individuals develop systematic ocular toxoplasmosis.9

Continue to: Toxoplasmosis and psychosis

Pages

Recommended Reading

Psychotropic med use tied to ‘striking’ post-COVID dementia risk
MDedge Psychiatry
Metacognitive training an effective, durable treatment for schizophrenia
MDedge Psychiatry
FDA okays first sublingual med for agitation in serious mental illness
MDedge Psychiatry
A new target in schizophrenia treatment: Brain gamma oscillations
MDedge Psychiatry
Novel long-acting injection cuts schizophrenia relapse
MDedge Psychiatry
‘Fragmented’ speech patterns may predict psychosis relapse
MDedge Psychiatry
Mental illness tied to COVID-19 breakthrough infection
MDedge Psychiatry
New combination med for severe mental illness tied to less weight gain
MDedge Psychiatry
High antipsychotic switch rates suggest ‘suboptimal’ prescribing for first-episode psychosis
MDedge Psychiatry
Virtual reality therapy promising for agoraphobia
MDedge Psychiatry